Naofumi Kunisawa Selected Research

(5,6-dimethoxyindan-2-yl)dipropylamine

1/2022

Mechanisms Underlying Dopaminergic Regulation of Nicotine-Induced Kinetic Tremor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naofumi Kunisawa Research Topics

Disease

8	Tremor (Tremors) 01/2022 - 07/2016
5	Seizures (Absence Seizure) 04/2019 - 01/2016
2	Essential Tremor (Essential Tremors) 01/2022 - 06/2018
2	Motor Disorders 04/2019 - 11/2015
2	Cognitive Dysfunction 01/2019 - 11/2015
2	Epilepsy (Aura) 11/2016 - 01/2016
1	Hypokinesia (Bradykinesia) 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Dementia (Dementias) 01/2019
1	Absence Epilepsy (Childhood Absence Epilepsy) 01/2019
1	Muscle Rigidity 01/2019
1	Psychotic Disorders (Schizoaffective Disorder) 01/2019
1	Parkinson Disease (Parkinson's Disease) 06/2018
1	Movement Disorders (Movement Disorder) 11/2016
1	Dyskinesias (Dyskinesia) 11/2015
1	Mood Disorders (Mood Disorder) 11/2015
1	Parkinsonian Disorders (Parkinsonism) 11/2015

Drug/Important Bio-Agent (IBA)

5	Nicotine FDA Link 01/2022 - 11/2016
3	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2019 - 11/2016
3	MecamylamineIBA 04/2019 - 11/2016
3	Pentylenetetrazole (Metrazol)IBA 01/2019 - 01/2016
2	Trihexyphenidyl (Artane)FDA LinkGeneric 04/2019 - 06/2018
2	Levodopa (L Dopa)FDA LinkGeneric 06/2018 - 11/2015
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 06/2018 - 11/2016
2	Serotonin ReceptorsIBA 06/2017 - 11/2015
2	methyllycaconitineIBA 01/2017 - 11/2016
1	SCH 23390IBA 01/2022
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2022
1	2,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)IBA 01/2022
1	Dopamine (Intropin)FDA LinkGeneric 01/2022
1	LigandsIBA 01/2022
1	(5,6-dimethoxyindan-2-yl)dipropylamineIBA 01/2022
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 04/2019
1	Paraoxon (E600)IBA 04/2019
1	Cholinesterases (Cholinesterase)IBA 04/2019
1	OrganophosphatesIBA 04/2019
1	Transcription Activator-Like EffectorsIBA 01/2019
1	Donepezil (Aricept)FDA LinkGeneric 01/2019
1	Antidepressive Agents (Antidepressants)IBA 01/2019
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2019
1	Galantamine (Galanthamine)FDA LinkGeneric 01/2019
1	Pilocarpine (Ocusert)FDA LinkGeneric 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2019
1	Antipsychotic Agents (Antipsychotics)IBA 01/2019
1	Carbamazepine (Tegretol)FDA LinkGeneric 06/2018
1	Phenobarbital (Luminal)FDA Link 06/2018
1	Bromocriptine (Parlodel)FDA LinkGeneric 06/2018
1	Propranolol (Inderal)FDA LinkGeneric 06/2018
1	Zonisamide (Zonegran)FDA LinkGeneric 06/2018
1	Levetiracetam (Keppra)FDA LinkGeneric 06/2018
1	Topiramate (Topamax)FDA LinkGeneric 06/2018
1	Gabapentin (Neurontin)FDA LinkGeneric 06/2018
1	2- (4- cyclopropylphenyl)- N- (1- (5- ((2,2,2- trifluoroethyl)oxo)pyridin- 2- yl)ethyl)acetamideIBA 06/2018
1	Valproic Acid (Depakote)FDA LinkGeneric 06/2018
1	Ethosuximide (Zarontin)FDA LinkGeneric 06/2018
1	Diazepam (Valium)FDA LinkGeneric 06/2018
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 12/2017
1	Serotonin AntagonistsIBA 06/2017
1	4-iodo-2,5-dimethoxyphenylisopropylamine (DOI-P)IBA 06/2017
1	SB 258585IBA 06/2017
1	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 06/2017
1	WAY 100135IBA 06/2017
1	RitanserinIBA 06/2017
1	Ondansetron (Zofran)FDA LinkGeneric 06/2017
1	Serotonin 5-HT1 Receptor AgonistsIBA 06/2017
1	Serotonin 5-HT2 Receptor AgonistsIBA 06/2017
1	Serotonin 5-HT3 Receptor AgonistsIBA 06/2017
1	Hexamethonium (Hexamethonium Bromide)IBA 11/2016
1	Potassium Channels (Potassium Channel)IBA 07/2016
1	Cyclic NucleotidesIBA 07/2016
1	N-acetylaspartate (N-acetyl aspartate)IBA 07/2016
1	aspartoacylaseIBA 07/2016
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2016